Strategies for the Prevention of Mother to Child Transmission in Western Countries: An Update

Background: During the last decades remarkable scientific advances have been made toward the prevention of HIV mother-to-child transmission, in particular in developed nations. The aim of this review was to analyze the latest findings and available international recommendations on the prevention of HIV mother-to-child transmission in high-income countries. Methods: We performed a literature search of the Cochrane Library, MEDLINE by PubMed and EMBASE from database inception through June 2014, using the following terms: HIV, mother-to-child transmission and mother-to-child-transmission prevention. All types of articles in the English language were included. US and available European guidelines were searched and included in the analysis. Results: One hundred fifty articles were selected for inclusion in this review. Conclusions: Global epidemiology of HIV infection is rapidly evolving, in particular in high-resource countries. The interpretation of clinical and epidemiological studies is crucial for the development of evidence-based recommendations to guide the management of HIV mother-to-child transmission. Although significant progress has been made, heterogeneity between countries in specific interventions still exists, which may address future research.

[1]  R. King,et al.  Confronting Challenges in Monitoring and Evaluation: Innovation in the Context of the Global Plan Towards the Elimination of New HIV Infections Among Children by 2015 and Keeping Their Mothers Alive , 2017, Journal of acquired immune deficiency syndromes.

[2]  D. Giacobbe,et al.  Factors Associated With Lack of Viral Suppression at Delivery , 2015, Annals of Internal Medicine.

[3]  Y. Gilleece,et al.  British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review) , 2014, HIV medicine.

[4]  L. Benjamins,et al.  Persistently High Perinatal Transmission of HIV: Assessment of Risk Factors , 2014, The Pediatric infectious disease journal.

[5]  C. Giaquinto,et al.  Pediatric human immunodeficiency virus infection and cancer in the highly active antiretroviral treatment (HAART) era. , 2014, Cancer letters.

[6]  M. Cortina-Borja,et al.  Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011 , 2014, AIDS.

[7]  C. Thorne,et al.  National Guidelines for the prevention of mother-to-child transmission of HIV across Europe - how do countries differ? , 2013, European journal of public health.

[8]  M. Lampe,et al.  Elimination of perinatal HIV infection in the USA and other high-income countries: achievements and challenges. , 2013, Current opinion in HIV and AIDS.

[9]  C. Guerreiro,et al.  Amniocentesis in HIV Pregnant Women: 16 Years of Experience , 2013, Infectious diseases in obstetrics and gynecology.

[10]  R. Bertz,et al.  Atazanavir Pharmacokinetics, Efficacy and Safety in Pregnancy: A Systematic Review , 2013, Antiviral therapy.

[11]  Peninnah Oberdorfer,et al.  Effects of antiretroviral drugs for prevention of HIV-mother-to-child transmission on hematological parameters and hemoglobin synthesis in HIV-uninfected newborns with and without thalassemia carrier. , 2013, Current HIV research.

[12]  M. Giles.  HIV and pregnancy: how to manage conflicting recommendations from evidence-based guidelines. , 2013, AIDS.

[13]  C. Giaquinto,et al.  Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants , 2013, AIDS.

[14]  M. Hicar.  Immunotherapies to prevent mother-to-child transmission of HIV. , 2013, Current HIV research.

[15]  Paige L. Williams,et al.  Combination antiretroviral use and preterm birth. , 2013, The Journal of infectious diseases.

[16]  A. Borkhardt,et al.  Risk adapted transmission prophylaxis to prevent vertical HIV–1 transmission: Effectiveness and safety of an abbreviated regimen of postnatal oral Zidovudine , 2013, BMC Pregnancy and Childbirth.

[17]  K. Brookfield,et al.  Duration of membrane rupture and risk of perinatal transmission of HIV-1 in the era of combination antiretroviral therapy. , 2012, American journal of obstetrics and gynecology.

[18]  J. Stringer,et al.  Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis , 2012, AIDS.

[19]  L. Mofenson,et al.  Three Postpartum Antiretroviral Regimens to Prevent Intrapartum HIV Infection , 2012 .

[20]  M. Santos,et al.  Low Rates of Mother-to-child Transmission of HIV-1 and Risk Factors for Infection in Spain: 2000–2007 , 2012, The Pediatric infectious disease journal.

[21]  E. Operskalski,et al.  The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  D. Hawkins,et al.  When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery? , 2012, AIDS.

[23]  C. Celum,et al.  Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions. , 2012, Current HIV research.

[24]  J. Singer,et al.  A national review of vertical HIV transmission , 2012, AIDS.

[25]  J. Read,et al.  Prevalence of Congenital Anomalies in Infants With In Utero Exposure to Antiretrovirals , 2012, The Pediatric infectious disease journal.

[26]  Markus Sköld,et al.  Tuberculosis and HIV Co-Infection , 2012, PLoS pathogens.

[27]  L. Mofenson,et al.  Unresolved Antiretroviral Treatment Management Issues in HIV-Infected Children , 2012, Journal of acquired immune deficiency syndromes.

[28]  F. Figueras,et al.  Association of HIV infection with spontaneous and iatrogenic preterm delivery: effect of HAART , 2012, AIDS.

[29]  V. V. Wong.  Is peripartum zidovudine absolutely necessary for patients with a viral load less than 1,000 copies/ml? , 2011, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[30]  N. Ford,et al.  Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis , 2011, AIDS.

[31]  S. Nanta,et al.  The Interrelated Transmission of HIV-1 and Cytomegalovirus During Gestation and Delivery in the Offspring of HIV-Infected Mothers , 2011, Journal of acquired immune deficiency syndromes.

[32]  A. Castelo,et al.  Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy. , 2011, AIDS reviews.

[33]  C. Giaquinto,et al.  Risk of perinatal HIV infection in infants born in Italy to immigrant mothers. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  M. Cortina-Borja,et al.  Insufficient Antiretroviral Therapy in Pregnancy: Missed Opportunities for Prevention of Mother-To-Child Transmission of HIV in Europe , 2011, Antiviral therapy.

[35]  L. Mandelbrot,et al.  Atazanavir in pregnancy: impact on neonatal hyperbilirubinemia. , 2011, European journal of obstetrics, gynecology, and reproductive biology.

[36]  J. Albert,et al.  Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations 2010 , 2011, Scandinavian journal of infectious diseases.

[37]  P. Gavin,et al.  Evaluation of 4 Weeks' Neonatal Antiretroviral Prophylaxis as a Component of a Prevention of Mother-to-child Transmission Program in a Resource-rich Setting , 2011, The Pediatric infectious disease journal.

[38]  M. Hughes,et al.  Increased Risk of Severe Infant Anemia After Exposure to Maternal HAART, Botswana , 2011, Journal of acquired immune deficiency syndromes.

[39]  Chengcheng Hu,et al.  Atazanavir Pharmacokinetics With and Without Tenofovir During Pregnancy , 2011, Journal of acquired immune deficiency syndromes.

[40]  L. Mofenson,et al.  Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication , 2011, Journal of perinatal medicine.

[41]  I. Vincenzi.  Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. , 2011 .

[42]  R. Bollinger,et al.  Maternal Tuberculosis: A Risk Factor for Mother-to-Child Transmission of Human Immunodeficiency Virus , 2011 .

[43]  M. Newell,et al.  Prevention of mother‐to‐child transmission of HIV in resource‐rich and ‐poor settings , 2011, BJOG : an international journal of obstetrics and gynaecology.

[44]  D. Jamieson,et al.  Prevention of mother-to-child transmission of HIV-1: the role of cesarean delivery. , 2010, Clinics in perinatology.

[45]  S. Ellington,et al.  HIV-1 and breastfeeding: biology of transmission and advances in prevention. , 2010, Clinics in perinatology.

[46]  M. Mirochnick,et al.  Antiretroviral pharmacology: special issues regarding pregnant women and neonates. , 2010, Clinics of Perinatology.

[47]  R. Sperling,et al.  Birth Defects Among Children Born to Human Immunodeficiency Virus-Infected Women: Pediatric AIDS Clinical Trials Protocols 219 and 219C , 2010, The Pediatric infectious disease journal.

[48]  M. Hughes,et al.  Antiretroviral regimens in pregnancy and breast-feeding in Botswana. , 2010, The New England journal of medicine.

[49]  Michael G Hudgens,et al.  Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. , 2010, The New England journal of medicine.

[50]  E. Livingston,et al.  Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy. , 2010, The Journal of infectious diseases.

[51]  M. Godfried,et al.  Mode of delivery in HIV‐infected pregnant women and prevention of mother‐to‐child transmission: changing practices in Western Europe , 2010, HIV medicine.

[52]  G. Aldrovandi,et al.  Antiretroviral Exposure and Lymphocyte mtDNA Content Among Uninfected Infants of HIV-1-Infected Women , 2009, Pediatrics.

[53]  C. Fortuny,et al.  ANTIRETROVIRAL-RELATED HEMATOLOGIC SHORT-TERM TOXICITY IN HEALTHY INFANTS: IMPLICATIONS OF THE NEW NEONATAL 4-WEEK ZIDOVUDINE REGIMEN , 2009, The Pediatric infectious disease journal.

[54]  D. Covington,et al.  Lopinavir/Ritonavir in Pregnancy , 2009, Journal of acquired immune deficiency syndromes.

[55]  C. Rouzioux,et al.  Decreased risk of congenital cytomegalovirus infection in children born to HIV-1-infected mothers in the era of highly active antiretroviral therapy. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[56]  John T Brooks,et al.  Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. , 2009, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[57]  H. Rees,et al.  Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa , 2009, AIDS.

[58]  M. Cortina-Borja,et al.  Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990–2007 , 2009, AIDS.

[59]  R. Tubiana,et al.  Amniocentesis and mother-to-child human immunodeficiency virus transmission in the Agence Nationale de Recherches sur le SIDA et les Hépatites Virales French Perinatal Cohort. , 2009, American journal of obstetrics and gynecology.

[60]  N. André,et al.  Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors , 2008, AIDS.

[61]  D. Rotten,et al.  Amniocentesis in pregnant HIV-infected patients. Absence of mother-to-child viral transmission in a series of selected patients. , 2008, European journal of obstetrics, gynecology, and reproductive biology.

[62]  M. Newell,et al.  Hepatitis B or hepatitis C coinfection in HIV‐infected pregnant women in Europe , 2008, HIV medicine.

[63]  Scott Rose,et al.  Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.

[64]  M. Cortina-Borja,et al.  Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006 , 2008, AIDS.

[65]  R. Tubiana,et al.  Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort , 2008, AIDS.

[66]  D. Zaknun,et al.  Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV‐1‐infected women , 2008, HIV medicine.

[67]  D. Cattaneo,et al.  Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer , 2007, AIDS.

[68]  Connie Celum,et al.  Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. , 2007, The Journal of infectious diseases.

[69]  S. Blanche.  Possible effet à long terme de l'exposition in utero aux antirétroviraux ? , 2007 .

[70]  D. Lehman,et al.  Biological mechanisms of vertical human immunodeficiency virus (HIV‐1) transmission , 2007, Reviews in medical virology.

[71]  F. Martin,et al.  Increased rates of preterm delivery are associated with the initiation of highly active antiretrovial therapy during pregnancy: a single-center cohort study. , 2007, The Journal of infectious diseases.

[72]  R. Gelber,et al.  Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA , 2007, BMC infectious diseases.

[73]  M. Hughes,et al.  In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children , 2007, AIDS.

[74]  T. Schmitz,et al.  Hematologic Effects of Maternal Antiretroviral Therapy and Transmission Prophylaxis in HIV-1-Exposed Uninfected Newborn Infants , 2007, Journal of acquired immune deficiency syndromes.

[75]  C. Larsen,et al.  Mortality after myocardial infarction in HIV-infected patients who have initiated HAART , 2007, AIDS.

[76]  O. Olivero.  Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors , 2007, Environmental and molecular mutagenesis.

[77]  P. Rustin,et al.  Clinical mitochondrial dysfunction in uninfected children born to HIV‐infected mothers following perinatal exposure to nucleoside analogues , 2007, Environmental and molecular mutagenesis.

[78]  G. McComsey,et al.  Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084. , 2007, American journal of obstetrics and gynecology.

[79]  C. Schmid,et al.  Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis , 2007, AIDS.

[80]  H. Tilson,et al.  Assessment of Birth Defects According to Maternal Therapy Among Infants in the Women and Infants Transmission Study , 2007, Journal of acquired immune deficiency syndromes.

[81]  S. Timmermans,et al.  The AmRo study: pregnancy outcome in HIV‐1‐infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery , 2007, BJOG : an international journal of obstetrics and gynaecology.

[82]  L. Mofenson,et al.  Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study. , 2006, The Journal of infectious diseases.

[83]  M. McPheeters,et al.  Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994–2003 , 2006, AIDS.

[84]  G. Duarte,et al.  Antiretroviral agents during pregnancy: consequences on hematologic parameters in HIV-exposed, uninfected newborn infant. , 2006, European journal of obstetrics, gynecology, and reproductive biology.

[85]  Peter B Gilbert,et al.  Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. , 2006, JAMA.

[86]  W. Fawzi,et al.  A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission , 2006, AIDS.

[87]  M. Cortina-Borja,et al.  Antiretroviral Therapy and Congenital Abnormalities in Infants Born to HIV-1-Infected Women in the United Kingdom and Ireland, 1990 to 2003 , 2006, Journal of acquired immune deficiency syndromes.

[88]  B. Luke,et al.  Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth? , 2006, The Journal of infectious diseases.

[89]  P. Williams,et al.  In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the pediatric AIDS clinical trials group 219 and 219C cohorts. , 2006, Journal of acquired immune deficiency syndromes.

[90]  W. Fawzi,et al.  The HPTN 024 Study: the efficacy of antibiotics to prevent chorioamnionitis and preterm birth. , 2006, American journal of obstetrics and gynecology.

[91]  T. Kuijpers,et al.  Haematological parameters of HIV‐1‐uninfected infants born to HIV‐1‐infected mothers , 2005, Acta paediatrica.

[92]  M. Newell,et al.  Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe , 2004, AIDS.

[93]  R. Artuch,et al.  Hyperlactatemia in Human Immunodeficiency Virus–Uninfected Infants Who Are Exposed to Antiretrovirals , 2004, Pediatrics.

[94]  R. Chaisson,et al.  Does tuberculosis increase HIV load? , 2004, The Journal of infectious diseases.

[95]  T. Kuijpers,et al.  Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers , 2004, AIDS.

[96]  M. Poirier,et al.  Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs. , 2004, Toxicology and Applied Pharmacology.

[97]  H. Coovadia,et al.  In utero HIV infection in pregnancies complicated by tuberculosis in Durban, South Africa , 2004, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[98]  W. Fawzi,et al.  Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. , 2004, The Journal of infectious diseases.

[99]  D. Covington,et al.  Risk of Birth Defects Associated With Nelfinavir Exposure During Pregnancy , 2004, Obstetrics and gynecology.

[100]  R. Gelber,et al.  Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316. , 2004, American journal of obstetrics and gynecology.

[101]  C. Guihenneuc‐Jouyaux,et al.  Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants , 2003, AIDS.

[102]  D. Money,et al.  Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy , 2003, The Pediatric infectious disease journal.

[103]  P. Rustin,et al.  Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort , 2003, AIDS.

[104]  G. Burstein,et al.  Sexually transmitted diseases treatment guidelines , 2003, Current opinion in pediatrics.

[105]  M. Newell,et al.  Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women. , 2003, Journal of acquired immune deficiency syndromes.

[106]  M. Hughes,et al.  Antiretroviral therapy during pregnancy and the risk of an adverse outcome. , 2002, The New England journal of medicine.

[107]  S. Vansteelandt,et al.  Placental Inflammation and Perinatal Transmission of HIV‐1 , 2002, Journal of acquired immune deficiency syndromes.

[108]  J. Hogan,et al.  Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[109]  R. Maserati,et al.  Factors associated with nucleic acids related to human immunodeficiency virus type 1 in cervico‐vaginal secretions , 2001, BJOG : an international journal of obstetrics and gynaecology.

[110]  C. Giaquinto,et al.  Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission. , 2001, AIDS.

[111]  Swiss Mother.  Combination antiretroviral therapy and duration of pregnancy , 2000, AIDS.

[112]  T. Rakusan.  Nucleoside Exposure in the Children of HIV‐Infected Women Receiving Antiretroviral Drugs: Absence of Clear Evidence for Mitochondrial Disease in Children Who Died Before 5 Years of Age in Five United States Cohorts , 2000, Journal of acquired immune deficiency syndromes.

[113]  J. Ibdah,et al.  Liver disease in pregnancy and fetal fatty acid oxidation defects. , 2000, Molecular genetics and metabolism.

[114]  R. Gray,et al.  Placental membrane inflammation and risks of maternal-to-child transmission of HIV-1 in Uganda. , 1999, Journal of acquired immune deficiency syndromes.

[115]  P. Rustin,et al.  Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues , 1999, The Lancet.

[116]  L. Kalish,et al.  Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. , 1999, The New England journal of medicine.

[117]  L. Kalish,et al.  Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[118]  C. Macken,et al.  The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy. , 1999, The Journal of infectious diseases.

[119]  A. Berrebi,et al.  Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. , 1998, JAMA.

[120]  R. Gelber,et al.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. , 1994, The New England journal of medicine.

[121]  T. Quinn,et al.  Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. , 1993, JAMA.

[122]  S. Ellington,et al.  The role of co-infections in mother-to-child transmission of HIV. , 2013, Current HIV research.

[123]  P. Rojo,et al.  Postexposure infant prophylaxis in high-risk situations of human immunodeficiency virus type 1 transmission. , 2012, The Pediatric infectious disease journal.

[124]  I. de Vincenzi,et al.  Antiretroviral drugs during breastfeeding for the prevention of postnatal transmission of HIV-1. , 2012, Advances in experimental medicine and biology.

[125]  Y. Gilleece,et al.  Guidelines for the management of HIV infection in pregnant women 2012 , 2012 .

[126]  L. Mofenson,et al.  Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants. , 2010, Journal of acquired immune deficiency syndromes.

[127]  V. Soriano,et al.  [Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy]. , 2009, Medicina clinica.

[128]  S. Blanche.  [Possible long-term effect of in utero antiretroviral exposure?]. , 2007, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[129]  June.  Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to reduce Perinatal HIV-1Transmission in the United States , 2003 .

[130]  J. Samet,et al.  Food and Drug Administration , 2007, BMJ : British Medical Journal.

[131]  L. van der Merwe,et al.  Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. , 2002, The Cochrane database of systematic reviews.

[132]  A. C. Primavesi.  Scheduled Cesarean Delivery and the Prevention of Vertical Transmission of HIV Infection , 1999 .

[133]  B. Korber,et al.  The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies. , 1999, The New England journal of medicine.

[134]  Organización Mundial de la Salud.  HIV and infant feeding: a guide for health care managers and supervisors , 1998 .